Standard BioTools Announces Agreement to Sell Microfluidics Business to ARCHIMED

Go back to Standard BioTools Announces Agreement to Sell Microfluidics Business to ARCHIMED
Labranche & Co (NASDAQ: LAB) Delayed: 0.69 +0.02 (2.99%)
Previous Close $0.67    52 Week High $4.47 
Open $0.68    52 Week Low $3.02 
Day High $0.70    P/E N/A 
Day Low $0.66    EPS $-1.56 
Volume 652,207